CJC-1295 No DAC / Ipamorelin Blend (5mg / 5mg) is a dual-peptide formulation supplied exclusively for controlled laboratory research. Each vial contains 5mg of CJC-1295 without DAC and 5mg of Ipamorelin in lyophilized form.
CJC-1295 without DAC is a synthetic growth hormone-releasing hormone analogue examined in laboratory models involving GHRH-receptor signaling. Ipamorelin is a synthetic peptide ligand associated with the growth hormone secretagogue receptor, GHS-R1a. Combining the two compounds allows researchers to investigate GH-axis signaling across two distinct receptor pathways.
This material is intended for in-vitro testing, analytical evaluation, receptor-binding studies, and other controlled laboratory experiments. Product identity and purity are evaluated through independent analytical testing, with batch-specific documentation available through the COA Library.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
The CJC-1295 without DAC and Ipamorelin blend is a dual-peptide formulation intended exclusively for controlled laboratory research involving GHRH-receptor and GHS-R1a-receptor signaling.
Each compound is associated with a separate receptor system within GH-axis research. The combined formulation allows investigators to examine receptor-specific signaling, temporal response patterns, pathway interactions, and analytical endpoints under standardized experimental conditions.
This product is supplied as a laboratory research material and is not represented as a drug, food, dietary supplement, cosmetic, or consumer product.
Blend Research Specifications:
| Product Name | CJC-1295 No DAC / Ipamorelin Blend |
| Composition | CJC-1295 without DAC 5mg + Ipamorelin 5mg |
| Product Format | Dual-peptide research blend |
| Unit Quantity | One vial |
| Form | Lyophilized powder |
| Source | Chemical synthesis |
| Molecular Formula | Component-specific; the blend is not represented by one molecular formula |
| Molecular Weight | Component-specific; the blend is not represented by one molecular-weight value |
| Sequence | Component-specific; confirm using the applicable analytical documentation |
| Purity and Identity | Evaluated through lot-specific analytical testing |
| Testing Documentation | Batch-specific Certificate of Analysis available through the COA Library |
| Storage Conditions | Store at or below -20°C in a dry environment protected from light, moisture, and temperature fluctuations |
| Research Classification | Laboratory research material only |
| Restrictions | Not for human or animal consumption, human use, veterinary use, clinical use, or any in-vivo procedure |
This formulation combines two synthetic peptides associated with separate GH-axis receptor pathways.
CJC-1295 without DAC is examined as a GHRH-receptor ligand in controlled laboratory models. Its no-DAC configuration is relevant to experiments designed around shorter-duration signaling intervals and time-dependent measurements.
Ipamorelin is examined as a ligand of the growth hormone secretagogue receptor, GHS-R1a. This pathway is distinct from GHRH-receptor activation, allowing the two materials to be evaluated separately or within a coordinated experimental design.
The combined formulation may be used to compare receptor activity, signaling intervals, GH pulse characteristics, assay sensitivity, and selected downstream laboratory markers. Experimental controls, validated analytical methods, and consistent sampling intervals are necessary when evaluating a multi-compound formulation.
Important Research Notice: NordSci peptides undergo independent analytical testing for identity and purity. Batch-specific Certificates of Analysis are available for laboratory documentation and quality-control review.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR HUMAN OR VETERINARY USE. NOT FOR DIAGNOSTIC, THERAPEUTIC, CLINICAL, FOOD, COSMETIC, OR DIETARY-SUPPLEMENT PURPOSES.
This blend may be examined in controlled GH-axis research models involving pulse timing, signal duration, response intervals, and measurable assay outputs. Its two-component composition allows researchers to evaluate signaling associated with GHRH and GHS-R1a receptor systems within the same experimental framework.
Laboratory studies may measure IGF-1 expression or other selected endocrine markers as analytical endpoints following receptor activation. These measurements require suitable controls, validated assays, defined sampling intervals, and documented experimental conditions.
The blend may be compared with individual CJC-1295 without DAC or Ipamorelin research materials. Comparative experiments can examine differences between single-receptor and dual-receptor study designs without assuming a predetermined result.
Multi-compound assay models may be used to examine receptor-pathway interactions, analytical variability, temporal signaling patterns, and control performance. Individual components may also be evaluated separately and documented as distinct experimental variables.
Consistent storage, labeling, documentation, and environmental controls are essential when working with a multi-peptide research formulation.
Laboratories should record the product name, lot number, receipt date, storage conditions, analytical documentation, and personnel responsible for material handling. All procedures must comply with institutional standard operating procedures and applicable regulations.
The material should remain clearly segregated from products intended for human or animal use. Access should be limited to trained laboratory personnel operating within authorized research environments.
No human, veterinary, diagnostic, therapeutic, food, cosmetic, dietary-supplement, or in-vivo use is permitted.
CJC-1295 No DAC / Ipamorelin Blend is available from NordSci Peptides as a laboratory research material. Each vial contains 5mg of CJC-1295 without DAC and 5mg of Ipamorelin in lyophilized form.
Product evaluation should include a review of lot identification, labeling, analytical documentation, storage requirements, and research-use restrictions.
Procurement Best Practices
IMPORTANT: This product is supplied exclusively for laboratory research. It is not for human or animal consumption, any in-vivo procedure, clinical use, veterinary use, or diagnostic or therapeutic purposes.
